➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

AstraZeneca
Express Scripts
Medtronic
McKesson
Johnson and Johnson
Dow

Last Updated: October 1, 2020

DrugPatentWatch Database Preview

Drugs in Development Information for Larazotide

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

What is the development status for investigational drug Larazotide?

Larazotide is an investigational drug.

There have been 4 clinical trials for Larazotide. The most recent clinical trial was a Phase 2 trial, which was initiated on October 1st 2018.

The most common disease conditions in clinical trials are Celiac Disease and [disabled in preview]. The leading clinical trial sponsors are Alba Therapeutics, Innovate Biopharmaceuticals, and Teva Pharmaceuticals USA.

There is one US patent protecting this investigational drug and twelve international patents.

Recent Clinical Trials for Larazotide
TitleSponsorPhase
Study to Evaluate the Efficacy and Safety of Larazotide Acetate for the Treatment of Celiac DiseaseInnovate BiopharmaceuticalsPhase 3
A Double-blind Placebo-controlled Study to Evaluate Larazotide Acetate for the Treatment of Celiac DiseaseTeva Pharmaceuticals USAPhase 2
A Double-blind Placebo-controlled Study to Evaluate Larazotide Acetate for the Treatment of Celiac DiseaseAlba TherapeuticsPhase 2

See all Larazotide clinical trials

Clinical Trial Summary for Larazotide

Top disease conditions for Larazotide
Top clinical trial sponsors for Larazotide

See all Larazotide clinical trials

International Patents for Larazotide

Drugname Country Document Number Estimated Expiration Related US Patent
Larazotide Australia 2008327846 2027-11-21   Start Trial
Larazotide Australia 2011201848 2027-11-21   Start Trial
Larazotide Canada 2707007 2027-11-21   Start Trial
Larazotide China 101918429 2027-11-21   Start Trial
Larazotide China 102241739 2027-11-21   Start Trial
Larazotide European Patent Office 2062909 2027-11-21   Start Trial
Larazotide European Patent Office 2222691 2027-11-21   Start Trial
>Drugname >Country >Document Number >Estimated Expiration >Related US Patent

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

AstraZeneca
Express Scripts
Medtronic
McKesson
Johnson and Johnson
Dow

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.